Tuesday, August 4, 2015

Pfizer gets European approval for $16bn Hospira acquisition

Pfizer is to sell assets including Infliximab biosimilar drug to sustain competition in the European market.

via IBTimes.co.uk : Articles by Jerin Mathew http://ift.tt/1DoXB93 August 05, 2015 at 09:52AM http://ift.tt/eA8V8J
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)